Mirion Technologies, Inc. provides radiation detection, measurement, and analysis solutions for customers operating in highly regulated and safety-sensitive environments. The company develops hardware, software, and services used to monitor radiation, protect personnel, manage nuclear materials, and support compliance with industry and government standards.
Its offerings include radiation detectors and spectrometers, personal dosimetry and health-physics systems, nuclear instrumentation and control equipment, contamination monitoring systems, and related data-management software. Mirion also supplies products for medical applications, including radiation monitoring and measurement technologies used in diagnostic imaging, radiation therapy, and nuclear medicine.
Mirion serves customers across the nuclear energy, healthcare, defense, scientific research, industrial, and homeland-security sectors. The company operates internationally and supports applications ranging from nuclear power generation and decommissioning to laboratory research and emergency response. Mirion became a publicly traded company on the New York Stock Exchange in 2021 following a business combination with a special-purpose acquisition company. Its leadership includes Chief Executive Officer Thomas D. Logan.
AI Generated. May Contain Errors.
Free MIR Stock Alerts